THE EGMS APPROVES THE TRANSFER OF COMPANY ASSETS

PT Kimia Farma Tbk ("KAEF") held an Extraordinary General Meeting of Shareholders (EGMS) on Monday, November 3, 2025, in Jakarta. The EGMS approved two agenda items: the transfer of the Company's assets and changes to the Company's management.

KAEF President Director, Djagad Prakasa Dwialam, stated, "Kimia Farma is currently undertaking a restructuring program to strengthen the Company's performance. One of the steps being taken is the transfer of the Company's assets, and the Extraordinary General Meeting of Shareholders has approved the transfer of the Company's assets. I would like to thank the shareholders for their support and approval of the Company's asset transfer plan. Through this plan, the Company is expected to obtain funds to support operational activities, working capital, and business development."

In addition, the EGMS approved changes to the composition of the Company's Board of Commissioners and Directors. Shareholders approved the honorable dismissal of Lina Sari as Director of Finance and Risk Management and Wiku Adisasmito as Commissioner. Shareholders also approved the honorable appointment of Willy Meridian as Director of Finance and Risk Management and Sumarjati Arjoso as Commissioner.

Djagad expressed his appreciation to the retiring Directors and Commissioners. "On behalf of the Company, I would like to express my gratitude and respect to Ms. Lina Sari and Mr. Wiku Adisasmito for their dedication and contributions in building and supporting Kimia Farma's improved performance," said Djagad.

"We believe the strategic decisions made by the shareholders at the EGMS are an important step for the Company's future growth. The Company will continue to strengthen its fundamentals, thereby enhancing competitiveness and driving sustainable growth," said Djagad.

The following is the new composition of KAEF's management, as decided by the EGMS on November 3, 2025:

Board of Commissioners

Board of Directors